Triple Giving November OMF logo

 TRIPLE YOUR IMPACT during Triple Giving November | All Donations to OMF are TRIPLED through December 3

Search
Close this search box.

Computational
Research Center
for Complex Diseases

From Data to Disease Mechanism and Treatments

About the research center

Each OMF funded study is selected, with oversight from our Scientific Advisory Board, for its ability to provide meaningful data that will fuel the search for treatment and diagnosis. This data is essential to develop diagnostic technologies, understand the molecular basis of the diseases, and uncover effective diagnostic tools and treatments. Under the direction of Wenzhong Xiao, PhD,  the Computational Research Center for Complex Diseases analyzes and integrates the data from OMF funded studies, an essential step in developing diagnostics and treatments.

Woman researcher in the distance, looking at computer
Wenzhong Xiao, PhD, headshot

Dr. Xiao is a world expert in computational genomics and the Director of the Immuno-Metabolic Computational Center at Massachusetts General Hospital (MGH), Harvard Medical School. He also leads a Computational Genomics Group at Stanford Genome Technology Center (SGTC). His research is at the interface of computation, genomics and medicine. In collaboration with Open Medicine Foundation, his lab analyzes studies on ME / CFS and compares ME / CFS with other diseases.

Active/Ongoing Studies

Severely ill Patient

The goal of the Severely ill Patient Study was to conduct a comprehensive “Big Data” analysis on severely ill ME/CFS patients in order to begin an exploration to find the molecular basis of ME/CFS.

Read More

Autoimmunity and Autoantibodies

The aim is to investigate potential differences in adrenergic and muscarinic receptor autoantibody levels in plasma and cerebrospinal fluid samples between ME/CFS patients and healthy controls.

Read More

Post-viral Encephalopathy

This study provides an excellent opportunity to understand the mechanism of long-lasting viral-induced cognitive complications, commonly referred to as “brain fog.”

Read More

Deep Proteome and Metabolome Profiling

Decode the molecular mechanisms underlying ME/CFS and contributing to specific symptoms with a particular emphasis of post-exertional malaise (PEM). This includes deep phenotyping of ME patients and global proteomic/metabolomics plasma profiling of ME..

Read More

Long COVID Clinic Studies

The aim is to investigate potential differences in adrenergic and muscarinic receptor autoantibody levels in plasma and cerebrospinal fluid samples between ME/CFS patients and healthy controls.

Read More

Stress-Activated MicroRNAs

Studying microRNAs could help to bridge the conceptual gap between genetic predisposition and environmental factors causing ME/CFS or exacerbating specific symptoms.

Read More

iCPET Omics Studies of ME/CFS

This Harvard study evaluates the different explanations of heart preload failure in ME/CFS patients to determine which is active in many, if not all, ME/CFS patients. The Computation Center is now seeking to better understand the causes of ME/CFS (PLF, the high flow type) as well as to identify potential drug targets for future therapies.

Read More

The Life Improvement Trial

The Life Improvement Trial (LIFT) aims to investigate two drugs, separately and in combination, Pyridostigmine (commonly known as Mestinon) and Low-Dose Naltrexone (LDN), for efficacy and to research the difference between responders and non-responders.

Read More

SUPPORT OMF Funded Critical Research

Please help us expand our research efforts across the globe. Every donation brings us closer to a fully-funded research effort and the answers we all seek.

Learn about Our Other OMF Funded Collaborative Research Centers

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.


How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669